Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
2021 · Science Immunology · 617 citations
https://doi.org/10.1126/sciimmunol.abl4340
D
Dany Anglicheau
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
386
Papers
14.0K
Citations
63
h-index
184
i10-index
Dany Anglicheau is an academic researcher from Délégation Paris 5. The author has contributed to research in topics: Renal Transplantation Outcomes and Treatments & Renal Diseases and Glomerulopathies & Organ Transplantation Techniques and Outcomes. The author has an h-index of 63, co-authored 329 publications.
ORCID: 0000-0001-5793-6174Papers by this author
worksIs COVID-19 infection more severe in kidney transplant recipients?
2020 · American Journal of Transplantation · 263 citations
https://doi.org/10.1111/ajt.16424
MicroRNAs in kidney injury and disease
2022 · Nature Reviews Nephrology · 185 citations
https://doi.org/10.1038/s41581-022-00608-6
Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection
2023 · Nature Communications · 112 citations
https://doi.org/10.1038/s41467-023-39859-7
Cell-free DNA for the detection of kidney allograft rejection
2024 · Nature Medicine · 100 citations
https://doi.org/10.1038/s41591-024-03087-3
COVID-19 severity in kidney transplant recipients is similar to nontransplant patients with similar comorbidities
2020 · American Journal of Transplantation · 78 citations
https://doi.org/10.1111/ajt.16416
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat